Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Enanta Pharmaceuticals (ENTA) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Q3 2025 value amounting to 0.22.

  • Enanta Pharmaceuticals' Asset Utilization Ratio rose 2874.29% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 2874.29%. This contributed to the annual value of 0.2 for FY2025, which is 2325.55% up from last year.
  • According to the latest figures from Q3 2025, Enanta Pharmaceuticals' Asset Utilization Ratio is 0.22, which was up 2874.29% from 0.21 recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.24 for Q1 2023, and its period low was 0.17 during Q4 2023.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.21 (2025), whereas its average is 0.2.
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Asset Utilization Ratio tumbled by 4218.92% in 2021, and later soared by 2874.29% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.21 in 2021, then grew by 7.4% to 0.23 in 2022, then decreased by 27.22% to 0.17 in 2023, then rose by 11.09% to 0.18 in 2024, then grew by 22.3% to 0.22 in 2025.
  • Its Asset Utilization Ratio was 0.22 in Q3 2025, compared to 0.21 in Q2 2025 and 0.19 in Q1 2025.